RxDoctor Payments Data

Munjal Shroff, DO

Psychiatry · Smyrna, GANPI 1093862948

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $264,010 of the $316,322 with a category attached, or 83.5%. 43 manufacturers reported payments, led by AbbVie at 57.2% of the total. Reporting peaked in 2022 at $95,226 and has fallen 62.9% since, to $35,292 in 2025. Among psychiatry clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$316,322in general payments, 2019–2025

Across 1,137 payments — averaging $278.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$181K
  • Corium, LLC$59K
  • Axsome Therapeutics, Inc.$40K
  • Supernus Pharmaceuticals, Inc.$28K
  • Jazz Pharmaceuticals Inc.$902
  • Otsuka America Pharmaceutical, Inc.$808
  • plus $7K from 37 others

What the payments were for

  • Consulting fees$23,0507%
  • Speaking & faculty fees$264,01083%
  • Travel & lodging$10,5293%
  • Food & beverage$18,6426%
  • Education$920%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$316,322 in reported general payments places this provider in the 95th percentile of 900 psychiatry providers in Georgia.

See all psychiatry providers in Georgia

Medicare billing

Part B allowed, 2024
$22,400
Medicare patients
75
Services billed
170

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
WakixPitolisant Hcl13$206,613
AuvelityDextromethorphan Hbr/Bupropion26$33,306
TrintellixVortioxetine Hydrobromide29$22,024
SuboxoneBuprenorphine Hcl/Naloxone Hcl19$15,081
SunosiSolriamfetol Hcl13$12,824
FetzimaLevomilnacipran Hcl12$9,188
Aripiprazole88$9,145
AzstarysSerdexmethylphen/Dexmethylphen20$8,204
Adderall XrDextroamphetamine/Amphetamine12$5,213
Armodafinil28$4,789
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl30$4,762
VyvanseLisdexamfetamine Dimesylate11$4,227
Lisdexamfetamine Dimesylate16$3,421
Duloxetine Hcl126$2,249
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine91$2,056

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Harmony Biosciences LLCWakix$653$206,61313 claims
Axsome Therapeutics, Inc.Auvelity, Sunosi$39,821$46,13039 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix, Vyvanse$472$26,25240 claims
Indivior Inc.Suboxone$245$15,08119 claims
AbbVieFetzima$180,912$9,18812 claims
Corium, LLCAzstarys$59,164$8,20420 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 900 psychiatry providers in Georgia.

Other psychiatry in Smyrna

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →